Indications |
Oral Palliative treatment of breast carcinoma Adult: 40 mg 4 times daily or 160 mg once daily. Oral Palliative treatment of endometrial carcinoma Adult: 40-320 mg daily in divided doses. Oral Anorexia and cachexia in patients with cancer or AIDS Adult: Initial: 800 mg daily. Usual range: 400-800 mg daily. As suspension containing 625 mg megestrol acetate in 5 ml: 625 mg daily. |
Contraindications |
Pregnancy and lactation. Severe hepatic impairment. |
Warnings / Precautions |
History of thrombophlebitis, mild to moderate hepatic impairment, risk of fluid retention, history of depression, diabetes, hypertension, renal or cardiac dysfunction. |
Adverse Reactions |
Acne, urticaria, fluid retention, wt gain, heart failure, nausea, vomiting, GI disturbances, changes in libido, breast discomfort, premenstrual symptoms, irregular menstrual cycles, depression, insomnia, somnolence, alopoecia, hirsutism, anaphylactoid-like reaction, jaundice, hot flushes, adrenocortical suppression, nausea, carpal tunnel syndrome, hypercalcaemia, tumour flare, hypertension. |
Drug Interactions |
Concentrations of indinavir may be reduced. Possible reduced efficacy of cisplatin. Warfarin half life may be increased. Megestrol concentration may be decreased by aminoglutethimide and enzyme-inducing drugs. See Below for More megestrol Drug Interactions |
Mechanism of Actions |
Megestrol is a progestogen used as an antineplastic and appetite stimulant. The mechanism of it's antineoplastic effects is not known but may be due to inhibition of oestrogen synthesis, modulation of other steroid hormones and/or a direct cytotoxic effect on tumour cells. Absorption: Variable absorption from the GIT (oral); peak plasma concentrations after 1-3 hrs. Distribution: Protein-binding: High. Metabolism: Hepatic. Excretion: Urine (as steroid metabolites and inactive compound), faeces. |
Administration |
Standard formulation: Should be taken with food. Megace ES: May be taken with or without food. |
ATC Classification |
G03AC05 - megestrol ; Belongs to the class of progestogens. Used as systemic contraceptives. G03DB02 - megestrol ; Belongs to the class of pregnadien derivative progestogens used in progestogenic hormone preparations. L02AB01 - megestrol ; Belongs to the class of progestogens. |
Available As |
|
Megestrol Acetate
Post Review about Megestrol Acetate Click here to cancel reply.
Megestrol Acetate Containing Brands
Megestrol Acetate is used in following diseases
Drug - Drug Interactions of Megestrol Acetate
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.